Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 37 results.
User Information
Export Records
  1. 1.   A Synthetic Mirror Image of Kalata B1 Reveals that Cyclotide Activity Is Independent of a Protein Receptor
  2. Sando, L.; Henriques, S. T.; Foley, F.; Simonsen, S. M.; Daly, N. L.; Hall, K. N.; Gustafson, K. R.; Aguilar, M. I.; Craik, D. J.
  3. Chembiochem. 2011, Nov; 12(16): 2456-2462.
  1. 2.   A Direct, Efficient Method for the Preparation of siRNAs Containing Ribo-like North Bicyclo[3.1.0]hexane Pseudosugars
  2. Terrazas, M.; Avino, A.; Siddiqui, M. A.; Marquez, V. E.; Eritja, R.
  3. Organic Letters. 2011, Jun; 13(11): 2888-2891.
  1. 3.   Effect of North Bicyclo[3.1.0]hexane 2 '-Deoxy-pseudosugars on RNA Interference: A Novel Class of siRNA Modification
  2. Terrazas, M.; Ocampo, S. M.; Perales, J. C.; Marquez, V. E.; Eritja, R.
  3. Chembiochem. 2011, May; 12(7): 1056-1065.
  1. 4.   Understanding the effects of carbocyclic sugars constrained to north and south conformations on RNA nanodesign
  2. Kim, T.; Barchi, J. J.; Marquez, V. E.; Shapiro, B. A.
  3. Journal of Molecular Graphics & Modelling. 2011, Feb; 29(5): 624-634.
  1. 5.   Structural studies of series HIV-1 nonnucleoside reverse transcriptase inhibitors 1-(2,6-difluorobenzyl)-2-(2,6-difluorophenyl)-benzimidazoles with different 4-substituents
  2. Ziolkowska, N. E.; Michejda, C. J.; Bujacz, G. D.
  3. Journal of Molecular Structure. 2010, Mar; 966(1-3): 53-58.
  1. 6.   Structure of HIV-1 nonnucleoside reverse transcriptase inhibitors derivatives of N-benzyl-benzimidazole with different substituents in position 4
  2. Ziolkowska, N. E.; Michejda, C. J.; Bujacz, G. D.
  3. Journal of Molecular Structure. 2010, Jan; 963(2-3): 188-193.
  1. 7.   Crystal structures of HIV-1 nonnucleoside reverse transcriptase inhibitors: N-benzyl-4-methyl-benzimidazoles
  2. Ziolkowska, N. E.; Michejda, C. J.; Bujacz, G. D.
  3. Journal of Molecular Structure. 2009 930(1-3): 157-161.
  1. 8.   Structural investigation of HIV-1 nonnucleoside reverse transcriptase inhibitors: 2-Aryl-substituted benzimidazoles
  2. Ziolkowska, N. E.; Michejda, C. J.; Bujacz, G. D.
  3. Journal of Molecular Structure. 2009 937(1-3): 34-38.
  1. 9.   Taxoids: Cancer-fighting compounds from nature
  2. Kingston, D. G. I.; Newman, D. J.
  3. Current Opinion in Drug Discovery & Development. 2007, Mar; 10(2): 130-144.
  1. 10.   Biophysical studies of DNA modified with conformationally constrained nucleotides: comparison of 2 '-exo (north) and 3 '-exo (south) 'locked' templates
  2. Maderia, M.; Shenoy, S.; Van, Q. N.; Marquez, V. E.; Barchi, J. J.
  3. Nucleic Acids Research. 2007, Mar; 35(6): 1978-1991.
  1. 11.   Development of a quantitative cell-based ELISA, for a humanized anti-IL-2/IL-15 receptor beta antibody (HuMik beta(1)), and correlation with functional activity using an antigen-transfected murine cell line
  2. Yang, X. Y.; Chen, E.; Jiang, H. G.; Hartmann, W. K.; Mitra, G.; Hecht, T.; Soman, G.
  3. Journal of Immunological Methods. 2006, APR 20; 311(1-2): 71-80.
  1. 12.   Evidence that sequence homologous region in LRAT-like proteins possesses anti-proliferative activity and DNA binding properties: translational implications and mechanism of action
  2. Simmons, D. P.; Peach, M. L.; Friedman, J. R.; Green, M. M. B.; Nicklaus, M. C.; De Luca, L. M.
  3. Carcinogenesis. 2006, Apr; 27(4): 693-707.
  1. 13.   Inhibition of transcription factor NF-kappa B signaling proteins IKK beta and p65 through specific cysteine residues by epoxyquinone A monomer: Correlation with its anti-cancer cell growth activity
  2. Liang, M. C.; Bardhan, S.; Pace, E. A.; Rosman, D.; Beutler, J. A.; Porco, J. A.; Gilmore, T. D.
  3. Biochemical Pharmacology. 2006, FEB 28; 71(5): 634-645.
  1. 14.   Solubility-enhancing proteins MBP and NusA play a passive role in the folding of their fusion partners
  2. Nallamsetty, S.; Waugh, D. S.
  3. Protein Expression and Purification. 2006, JAN; 45(1): 175-182.
  1. 15.   Evaluating chemical structure similarity as an indicator of cellular growth inhibition
  2. Wallqvist, A.; Huang, R. L.; Thanki, N.; Covell, D. G.
  3. Journal of Chemical Information and Modeling. 2006, JAN-FEB; 46(1): 430-437.
  1. 16.   International collaboration in drug discovery and development from natural sources
  2. Cragg, G. M.; Newman, D. J.
  3. Pure and Applied Chemistry. 2005, NOV; 77(11): 1923-1942.
  1. 17.   Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)- and (E)-combretastatin A-4
  2. Pettit, G. R.; Rhodes, M. R.; Herald, D. L.; Hamel, E.; Schmidt, J. M.; Pettitt, R. K.
  3. Journal of Medicinal Chemistry. 2005, JUN 16; 48(12): 4087-4099.
  1. 18.   Ring-closing metathesis of C-terminal allylglycine residues with an N-terminal beta-vinyl-substituted phosphotyrosyl mimetic as an approach to novel Grb2 SH2 domain-binding macrocycles
  2. Oishi, S.; Shi, Z. D.; Worthy, K. M.; Bindu, L. K.; Fisher, R. J.; Burke, T. R.
  3. Chembiochem. 2005, APR; 6(4): 668-674.
  1. 19.   Purified Bacillus anthracis lethal toxin complex formed in Vitro and during infection exhibits functional and biological activity
  2. Panchal, R. G.; Halverson, K. M.; Ribot, W.; Lane, D.; Kenny, T.; Abshire, T. G.; Ezzell, J. W.; Hoover, T. A.; Powell, B.; Little, S.; Kasianowicz, J. J.; Bavari, S.
  3. Journal of Biological Chemistry. 2005, MAR 18; 280(11): 10834-10839.
  1. 20.   Selective inhibition of HIV-1 reverse transcriptase-associated ribonuclease H activity by hydroxylated tropolones
  2. Budihas, S. R.; Gorshkova, I.; Gaidamakov, S.; Wamiru, A.; Bona, M. K.; Parniak, M. A.; Crouch, R. J.; McMahon, J. B.; Beutler, J. A.; Le Grice, S. F. J.
  3. Nucleic Acids Research. 2005 33(4): 1249-1256.
  1. 21.   Secondary metabolites of Phlomis viscosa and their biological activities
  2. Calis, I.; Kirmizibekmez, H.; Beutler, J. A.; Donmez, A. A.; Yalcin, F. N.; Kilic, E.; Ozalp, M.; Ruedi, P.; Tasdemir, D.
  3. Turkish Journal of Chemistry. 2005 29(1): 71-81.
  1. 22.   Quantitative profiling of the detergent-resistant membrane proteome of Iota-b toxin induced Vero cells
  2. Blonder, J.; Hale, M. L.; Chan, K. C.; Yu, L. R.; Lucas, D. A.; Conrads, T. P.; Zhou, M.; Popoff, M. R.; Issaq, H. J.; Stiles, B. G.; Veenstra, T. D.
  3. Journal of Proteome Research. 2005, MAR-APR; 4(2): 523-531.
  1. 23.   JAK/STAT signaling regulates tissue outgrowth and male germline stem cell fate in Drosophila
  2. Singh, S. R.; Chen, X.; Hou, S. X.
  3. Cell Research. 2005, JAN; 15(1): 1-5.
  1. 24.   Design and synthesis of novel indole beta-diketo acid derivatives as HIV-1 integrase inhibitors
  2. Sechi, M.; Derudas, M.; Dallocchio, R.; Dessi, A.; Bacchi, A.; Sannia, L.; Carta, F.; Palomba, M.; Ragab, O.; Chan, C.; Shoemaker, R.; Sei, S.; Dayam, R.; Neamati, N.
  3. Journal of Medicinal Chemistry. 2004, OCT 7; 47(21): 5298-5310.
  1. 25.   The role of the cyclic peptide backbone in the anti-HIV activity of the cyclotide kalata B1
  2. Daly, N. L.; Gustafson, K. R.; Craik, D. J.
  3. Febs Letters. 2004, SEP 10; 574(1-3): 69-72.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel